As-required versus regular nebulized salbutamol for the treatment of acute severe asthma. 1999

P Bradding, and I Rushby, and J Scullion, and M D Morgan
Dept of Respiratory Medicine and Thoracic Surgery, The Glenfield Hospital, Leicester, UK.

Current British guidelines for the administration of beta2-agonists in acute severe asthma recommend regular nebulized therapy in hospitalized patients, followed by as-required (p.r.n.) use via hand-held devices after discharge. Since beta2-agonists do not possess anti-inflammatory activity in vivo, and are thus unlikely to influence the rate of recovery from an asthma exacerbation, it was hypothesized that patients given the short-acting beta2-agonist salbutamol on an as-required basis after admission to hospital would recover as quickly as those on regular treatment, but with potential reductions in the total dose delivered. Forty-six patients with acute severe asthma were randomly assigned to either regular prescriptions of nebulized salbutamol or to usage on a p.r.n. basis, from 24 h after hospital admission. The primary outcome measures were length of hospital stay, time to recovery, and frequency of salbutamol nebulization from 24 h after admission to discharge. Secondary outcome measures were treatment side-effects (tremor, palpitations), and patient satisfaction. Length of hospital stay was reduced in those patients allocated to p.r.n. salbutamol (geometric mean (GM) 3.7 days) versus regular salbutamol (GM 4.7 days). Time taken for peak expiratory flow to reach 75% of recent best was the same in both groups. There was a highly significant reduction in the number of times nebulized therapy was delivered to the p.r.n. group (GM 7.0, range 1-30) compared with the regular treatment group (GM 14.0, range 4-57; p=0.003; 95% confidence interval for ratio of GMs 1.29-3.09). In addition, patients reported less tremor (p=0.062) and fewer palpitations (p=0.049) in the p.r.n. group. Of the patients in the p.r.n. group who had received regular nebulized therapy on previous admissions (n=12), all preferred the p.r.n. regimen. Prescribing beta2-agonists on a p.r.n. basis from 24 h after hospital admission is associated with reduced amount of drug delivered, incidence of side-effects, and possibly length of hospital stay. This has implications for the efficient use of healthcare resources.

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010366 Peak Expiratory Flow Rate Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR. Expiratory Peak Flow Rate,Flow Rate, Peak Expiratory,PEFR
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

P Bradding, and I Rushby, and J Scullion, and M D Morgan
August 1998, The European respiratory journal,
P Bradding, and I Rushby, and J Scullion, and M D Morgan
December 1986, The Ceylon medical journal,
P Bradding, and I Rushby, and J Scullion, and M D Morgan
November 1995, The American journal of emergency medicine,
P Bradding, and I Rushby, and J Scullion, and M D Morgan
January 1998, The American journal of emergency medicine,
P Bradding, and I Rushby, and J Scullion, and M D Morgan
March 2016, JPMA. The Journal of the Pakistan Medical Association,
P Bradding, and I Rushby, and J Scullion, and M D Morgan
February 2000, The American journal of medicine,
P Bradding, and I Rushby, and J Scullion, and M D Morgan
August 1994, Lancet (London, England),
P Bradding, and I Rushby, and J Scullion, and M D Morgan
October 2011, International journal of clinical pharmacology and therapeutics,
P Bradding, and I Rushby, and J Scullion, and M D Morgan
January 1995, Intensive care medicine,
P Bradding, and I Rushby, and J Scullion, and M D Morgan
July 1984, Archives of disease in childhood,
Copied contents to your clipboard!